Domů › Mnohočetný myelom › New York › Queens
Klinické studie Mnohočetný myelom v Queens, NY
20 studií pro Mnohočetný myelom hledá účastníky v lokalitách v Queens a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Probíhá náborFáze 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · Vzdálenost 13 mi
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · Vzdálenost 11 mi
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 3
- NYU Winthrop, Mineola · Vzdálenost 11 mi
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Probíhá náborFáze 3
- Northwell Health Cancer Institute, Lake Success · Vzdálenost 9 mi
- NYU Langone Hospital Long Island, Mineola · Vzdálenost 11 mi
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Probíhá náborFáze 3
- MSK Nassau, Uniondale · Vzdálenost 13 mi
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Probíhá náborFáze 2
- Queens Cancer Center, Rego Park · Vzdálenost 3 mi
- Cohen Children's Medical Center, New Hyde Park · Vzdálenost 9 mi
- Northwell Health Monter Cancer Center, Lake Success · Vzdálenost 9 mi
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Probíhá náborFáze 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · Vzdálenost 13 mi
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Probíhá náborFáze 3
- Long Island Jewish Medical Center, New Hyde Park · Vzdálenost 9 mi
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · Vzdálenost 9 mi
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Probíhá náborFáze 3
- MSK Nassau, Uniondale · Vzdálenost 13 mi
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Probíhá náborFáze 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · Vzdálenost 13 mi
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Probíhá náborFáze 3
- Research Site, New Hyde Park · Vzdálenost 9 mi
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Probíhá náborObservační studie
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · Vzdálenost 10 mi
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · Vzdálenost 13 mi
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Probíhá náborFáze 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · Vzdálenost 13 mi
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Probíhá náborFáze 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · Vzdálenost 13 mi
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Probíhá náborFáze 1/2
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · Vzdálenost 11 mi
A Dietary Study for People With Multiple Myeloma
Probíhá nábor
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · Vzdálenost 13 mi
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Probíhá náborFáze 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · Vzdálenost 13 mi
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Memorial Sloan Kettering Rockville, Rockville Centre · Vzdálenost 10 mi
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Probíhá nábor
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · Vzdálenost 13 mi
Studie Mnohočetný myelom v jiných městech
- New York City, NY60 studií
- Boston, MA42 studií
- Atlanta, GA41 studií
- Houston, TX38 studií
- Durham, NC37 studií
- Nashville, TN32 studií
- Denver, CO27 studií
- Rochester, MN24 studií
- St. Louis, MO24 studií
- Columbus, OH24 studií
- Baldwin Park, CA23 studií
- Chicago, IL22 studií
Další studie v Queens
- Rakovina prsu63 studií
- Nemalobuněčný plicní karcinom49 studií
- Kolorektální karcinom31 studií
- Metastatický karcinom28 studií
- Rakovina vaječníků28 studií
- Rakovina prostaty27 studií
- Rakovina (všechny typy)26 studií
- Rakovina endometria25 studií
- Rakovina plic22 studií
- Akutní myeloidní leukemie21 studií
- Squamózní buněčný karcinom hlavy a krku20 studií
- Rakovina slinivky břišní20 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.